Abstract:Abstract Metastasis is a major barrier to long-term survival and therapeutic options for aggressive, metastatic forms of breast cancer remain limited. Studies using patient samples have identified tumor-resident bacteria that preferentially associate with specific breast cancer types, however, it is not yet understood how intratumoral bacteria directly contributes to disease progression and metastatic propensity independent of other prognostic factors. It is therefore the goal of the Dedhar and Finlay labs to identify how specific bacteria within metastatic breast cancer control immune and tumor cell functions to regulate metastatic potential and determine the outcome of disease progression. Using the syngenic, immunocompetent 4T1 and 67NR breast cancer models of metastatic and non-metastatic disease, we found microbiome depletion significantly reduces primary tumor growth of highly metastatic 4T1 tumors specifically. We also found bacterial depletion reduces metastatic burden and extends survival time compared to microbiome-replete controls. Microbiome depletion also induces changes in immune cell function that occur specifically in the metastatic 4T1 tumors, revealing differential microbial-based regulation of metastatic versus non-metastatic disease. To identify bacteria that control metastasis in microbiome-replete controls, we plated surgically resected tumor suspensions on bacterial growth media and compared bacteria from the 4T1 and 67NR primary tumors. We identified several species of the Bacillus genus that were unique to 4T1 tumors and were present both within the primary tumor as well as metastatic nodules. We then designed several in vivo model systems to directly test the ability of the isolated bacteria to promote metastasis. Using an orthotopic inoculation model with 4T1 or EMT6 cells, we found that following intratumoral injection, the 4T1-derived Bacillus species was actually able to augment metastasis when introduced directly back into primary tumors. To determine the specificity of this phenomenon, we then compared the effects of the 4T1 and 67NR-isolated bacteria on metastasis by injecting 4T1 cells that had been co-cultured with either bacteria prior to injection. Interestingly, we found that while the 67NR-derived bacteria had little effect on metastasis, the 4T1-derived Bacillus species significantly enhanced metastatic tumor burden compared to all other groups including those cultured with the 67NR-derived bacteria. These data demonstrate the ability of certain bacteria to promote metastatic disease. Based on these findings, we hypothesize specific bacteria play a causative role in augmenting metastatic propensity, and seek to determine functional differences between intratumoral bacteria to identify mechanistic targets for prevention of metastasis. We also seek to expand this work into clinical models to identify potential prognostic factors as well as mechanistic targets for disease treatment. Citation Format: Zachary J. Gerbec, Antonio Serapio-Palacios, Sarah Woodward, Jorge Pena-Diaz, B Brett Finlay, Shoukat Dedhar. Tumor-derived bacteria drive breast cancer metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5897.

Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer

Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response.

Abstract 5897: Tumor-derived bacteria drive breast cancer metastasis

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

The crosstalk of intratumor bacteria and the tumor

Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites

Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer

Microbiota in tumors: new factor influencing cancer development

Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities

The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer

Awareness of intratumoral bacteria and their potential application in cancer treatment

Spatial meta-transcriptomics reveal intratumor bacterial association with lung cancer cells showing a distinct oncogenic signature.

Intracellular bacteria in cancer—prospects and debates

Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer

Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics

Abstract B030: Spatial coupling of microbes and immune cells shapes the tumor microenvironment in human cancers

Microbiota in cancer: molecular mechanisms and therapeutic interventions

Intratumoral microbiota in colorectal cancer: focus on specific distribution and potential mechanisms

Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies